Christopher Yea, CHIEF DEVELOPMENT OFFICER at KalVista Pharmaceuticals, Inc. (KALV), sold 79,772 shares at $15.01 ($1.2M) on 2024-02-14, disclosed to the SEC on 2024-02-16.
Open-market sale of $1.2M KALV by CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.01 | 39,886 | $599K | 50.0% |
| 2 | $15.01 | 39,886 | $599K | 50.0% |
| Total | $15.01 avg | 79,772 | $1.2M | 100% |
| Filing → |
| KALV | SELL | 2026-05-26 | $63K | — | Filing → |
| KALV | SELL | 2026-05-19 | $30K | — | Filing → |
| KALV | SELL | 2026-02-24 | $68K | — | Filing → |